Announcements Trials

Browse Landscape

Status

Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7 Neoplasms 4 Breast Neoplasms 4 Recurrence 3 Colonic Neoplasms 3 Rectal Neoplasms 2 Neoplasm Metastasis 2 Tuberous Sclerosis 1 Seizures 1 Rectal Diseases 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms by Site 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Multiple Myeloma 1 Lung Neoplasms 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Inflammation 1 Gastrointestinal Neoplasms 1 Gastrointestinal Hemorrhage 1 Gastrointestinal Diseases 1 Epilepsy 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Colonic Diseases 1 Cognitive Dysfunction 1 Carcinoma, Squamous Cell 1

Interventions

Gemcitabine 78 Fluorouracil 27 Oxaliplatin 24 130-nm albumin-bound paclitaxel 24 Leucovorin 18 Capecitabine 15 Albumin-Bound Paclitaxel 15 S 1 (combination) 14 Taxes 12 Irinotecan 11 pembrolizumab 9 folfirinox 9 Radiosurgery 9 Radiotherapy 7 Drug Therapy 7 Cisplatin 7 irinotecan sucrosofate 6 Pancreaticoduodenectomy 5 Paclitaxel 5 Injections 5 Docetaxel 5 Blood Specimen Collection 5 apatinib 4 Radiofrequency Ablation 4 Radiation 4 Biopsy 4 tislelizumab 3 rubitecan 3 nimotuzumab 3 camrelizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Aspirin × Clear all

NCT04245644 2024-03-12

CAOS

IRCCS San Raffaele

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡